BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21669386)

  • 1. Perspectives on "early dialogue" between a manufacturer and health technology assessment agencies.
    Geisler BP
    Value Health; 2011 Jun; 14(4):607. PubMed ID: 21669386
    [No Abstract]   [Full Text] [Related]  

  • 2. Early dialogue between the developers of new technologies and pricing and reimbursement agencies: a pilot study.
    Backhouse ME; Wonder M; Hornby E; Kilburg A; Drummond M; Mayer FK
    Value Health; 2011 Jun; 14(4):608-15. PubMed ID: 21669387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health technology assessment (HTA) increasingly important in spine research.
    van Tulder M
    Eur Spine J; 2011 Jul; 20(7):999-1000. PubMed ID: 21720729
    [No Abstract]   [Full Text] [Related]  

  • 4. Biosimilars: evidential standards for health technology assessment.
    Hughes DA
    Clin Pharmacol Ther; 2010 Mar; 87(3):257-61. PubMed ID: 20160743
    [No Abstract]   [Full Text] [Related]  

  • 5. The need for Health Technology Assessments of PET.
    Van Tinteren H; Hoekstra OS; Boers M
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1438-9; author reply 1439. PubMed ID: 12898206
    [No Abstract]   [Full Text] [Related]  

  • 6. Health technology assessment of PET in oncology: re Eur J Nucl Med Mol Imaging 2003; 30:637-641.
    Kristensen FB; Adams E; Briones E; Coburn D; Facey K; Hansen NW; Hoeksema J; Mørland B
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):295-7; author reply 297-8; discussion 298. PubMed ID: 15129712
    [No Abstract]   [Full Text] [Related]  

  • 7. Health technology assessment in Europe.
    Kristensen FB
    Scand J Public Health; 2009 Jun; 37(4):335-9. PubMed ID: 19493989
    [No Abstract]   [Full Text] [Related]  

  • 8. Are health technology assessments a reliable tool in th analysis of the clinical value of PET in oncology? Who audits the auditors?
    Højgaard L
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):637-41. PubMed ID: 12838956
    [No Abstract]   [Full Text] [Related]  

  • 9. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Written in the stars. Introducing our five-star rating system.
    Health Devices; 2010 Mar; 39(3):73. PubMed ID: 21309267
    [No Abstract]   [Full Text] [Related]  

  • 11. Health Technology Assessment: managing the introduction and use of medical devices in clinical practice in Italy.
    Migliore A; Ratti M; Cerbo M; Jefferson T
    Expert Rev Med Devices; 2009 May; 6(3):251-7. PubMed ID: 19419283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NICE Health Technology Appraisal Programme.
    Burchell M; Ruiz F; Barnett D
    Ann R Coll Surg Engl; 2005 Jul; 87(4):283-4. PubMed ID: 16884603
    [No Abstract]   [Full Text] [Related]  

  • 13. Health technology assessment from a Canadian device industry perspective.
    Ferrusi IL; Ames D; Lim ME; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):353-9. PubMed ID: 19394576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovation. How ideas see the light.
    Health Serv J; 2010 Feb; 120(6195):31. PubMed ID: 20337257
    [No Abstract]   [Full Text] [Related]  

  • 15. Some alternative perspectives concerning medical technology assessment.
    Diamond GA
    J Invasive Cardiol; 1992; 4(1):39-44. PubMed ID: 10149903
    [No Abstract]   [Full Text] [Related]  

  • 16. Scanning the horizon of obsolete technologies: possible sources for their identification.
    Ibargoyen-Roteta N; Gutierrez-Ibarluzea I; Asua J; Benguria-Arrate G; Galnares-Cordero L
    Int J Technol Assess Health Care; 2009 Jul; 25(3):249-54. PubMed ID: 19619342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicines regulation and health technology assessment.
    Breckenridge A; Woods K; Walley T
    Clin Pharmacol Ther; 2010 Feb; 87(2):152-4. PubMed ID: 20107448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAMI Standards: A History of Ensuring Medical Technology Quality and Performance.
    Lewelling J
    Biomed Instrum Technol; 2017; 51(3):210-211. PubMed ID: 28530882
    [No Abstract]   [Full Text] [Related]  

  • 19. Why rankings of biomedical image analysis competitions should be interpreted with care.
    Maier-Hein L; Eisenmann M; Reinke A; Onogur S; Stankovic M; Scholz P; Arbel T; Bogunovic H; Bradley AP; Carass A; Feldmann C; Frangi AF; Full PM; van Ginneken B; Hanbury A; Honauer K; Kozubek M; Landman BA; März K; Maier O; Maier-Hein K; Menze BH; Müller H; Neher PF; Niessen W; Rajpoot N; Sharp GC; Sirinukunwattana K; Speidel S; Stock C; Stoyanov D; Taha AA; van der Sommen F; Wang CW; Weber MA; Zheng G; Jannin P; Kopp-Schneider A
    Nat Commun; 2018 Dec; 9(1):5217. PubMed ID: 30523263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid response in health technology assessment: a Delphi study for a Brazilian guideline.
    Silva MT; Silva END; Barreto JOM
    BMC Med Res Methodol; 2018 Jun; 18(1):51. PubMed ID: 29884121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.